| INSR |
INSR: Insulin receptor precursor |
PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
0.477 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
O
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
0.477 |
Evidence |
O
|
| KNG1 |
KNG1, BDK, KNG: Kininogen-1 precursor |
CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
0.477 |
Evidence |
|
| KNG1 |
KNG1, BDK, KNG: Kininogen-1 precursor |
CTSB |
CTSB, CPSB: Cathepsin B precursor |
0.477 |
Evidence |
|
| KNG1 |
KNG1, BDK, KNG: Kininogen-1 precursor |
CTSL |
CTSL: Cathepsin L precursor |
0.477 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
TFAP4 |
TFAP4: Transcription factor AP-4 |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
MAX |
MAX: Protein max |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
MYF5 |
MYF5: Myogenic factor 5 |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
0.477 |
Evidence |
|
| MITF |
IPI00023896 |
HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
0.477 |
Evidence |
|
| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
KNG1 |
KNG1, BDK, KNG: Kininogen-1 precursor |
0.477 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
FLT4 |
VEGFR3 long form |
0.477 |
Evidence |
|
| ZNF264 |
ZNF264, KIAA0412: Zinc finger protein 264 |
ZNF174 |
ZNF174, ZSCAN8: Zinc finger protein 174 |
0.477 |
Evidence |
|